Also, our CEO said the funding will help with cons
Post# of 15624
"This financing is an important milestone for the company," said Mordechai Bignitz, CEO of OWC Pharmaceutical Research. "It enables us to continue to invest in the research and development of our products and to progress our clinical development, which is key to the uniqueness of our company. With this financing, we can also consolidate our movement to commercialization of our first products. We are also very happy to strengthen the institutional presence amongst our shareholders."